Outcomes from lateral eyelid coupling for facial paralysis using the modified tarsoconjunctival flap

Raj Dedhia, Tsung Yen Hsieh, Oliver Chin, Taha Z. Shipchandler, Travis Tate Tollefson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

IMPORTANCE In the setting of facial paralysis, inadequate eyelid closure and lower eyelid ectropion can lead to corneal exposure and impaired quality of life. Repair of paralytic ectropion is challenging, and an ideal surgical approach for all cases has not been identified. OBJECTIVE To assess the patient-reported outcomes and eyelid position improvement in patients with flaccid facial paralysis undergoing lateral eyelid coupling with a tarsal strip canthoplasty and modified tarsoconjunctival flap to correct eyelid malposition. DESIGN, SETTING, AND PARTICIPANTS Review of medical records of adults with flaccid facial paralysis who underwent a single-stage tarsal strip canthoplasty and modified tarsoconjunctival flap at a tertiary academic center. Inclusion criteria included a minimum of 3 months of follow-up. INTERVENTION The lateral upper and lower eyelid are coupled with the hybrid tarsoconjunctival flap. MAIN OUTCOMES AND MEASURES Patient-reported outcome measures and objective photograph analysis. Preoperative and postoperative Facial Clinimetric Evaluation (FaCE) scores and Moe Ectropion Grading Scale scores were compared. The relationship between radiation therapy (RT) and outcomes was analyzed. RESULTS Sixteen patients (8 [50%] female; mean [SD] age at surgery, 71.5 [9.6] years) were identified between January 2014 and August 2017. Twelve (75%) had paralysis from facial nerve sacrifice during cancer ablation. The mean time between paralysis and referral for surgical repair of ectropion was 23 months (range, 0-151 months) and mean follow-up after surgery was 9.8 months (range, 3-39 months). The most common symptom was epiphora, which was significantly reduced after surgery (75% vs 25%; P = .01). Median Moe Ectropion Grading Scale score improved from 3 (interquartile range, 2-3) to 0 (interquartile range, 0-1; P < .001). Quality of life measured using the FaCE scale demonstrated a significant improvement in mean eye comfort (from 18.8 [95% CI, 2.3-35.2] to 47.9 [95% CI, 31.9-63.9]; P = .01) and lacrimal control scores (from 12.5 [95% CI, 0-29.2] to 45.8 [95% CI, 29.3-62.3]; P = .03) in the 6 patients in the RT group, but no difference in the 4 patients in the non-RT group. CONCLUSIONS AND RELEVANCE Ocular symptoms, eyelid appearance, and quality of life were improved after lateral eyelid coupling among patients with flaccid facial paralysis and paralytic ectropion. The tarsoconjunctival flap does limit peripheral vision, but is reversible if dynamic eyelid closure is returned with nerve grafting.

Original languageEnglish (US)
Pages (from-to)381-386
Number of pages6
JournalJAMA Facial Plastic Surgery
Volume20
Issue number5
DOIs
StatePublished - Sep 1 2018

Fingerprint

Facial Paralysis
Eyelids
Ectropion
Quality of Life
Paralysis
Radiotherapy
Lacrimal Apparatus Diseases
Facial Nerve
Group Psychotherapy
Tears
Medical Records
Referral and Consultation

ASJC Scopus subject areas

  • Surgery

Cite this

Outcomes from lateral eyelid coupling for facial paralysis using the modified tarsoconjunctival flap. / Dedhia, Raj; Hsieh, Tsung Yen; Chin, Oliver; Shipchandler, Taha Z.; Tollefson, Travis Tate.

In: JAMA Facial Plastic Surgery, Vol. 20, No. 5, 01.09.2018, p. 381-386.

Research output: Contribution to journalArticle

Dedhia, Raj ; Hsieh, Tsung Yen ; Chin, Oliver ; Shipchandler, Taha Z. ; Tollefson, Travis Tate. / Outcomes from lateral eyelid coupling for facial paralysis using the modified tarsoconjunctival flap. In: JAMA Facial Plastic Surgery. 2018 ; Vol. 20, No. 5. pp. 381-386.
@article{aa93dbd9b4934ccdadeb2aed51bf85be,
title = "Outcomes from lateral eyelid coupling for facial paralysis using the modified tarsoconjunctival flap",
abstract = "IMPORTANCE In the setting of facial paralysis, inadequate eyelid closure and lower eyelid ectropion can lead to corneal exposure and impaired quality of life. Repair of paralytic ectropion is challenging, and an ideal surgical approach for all cases has not been identified. OBJECTIVE To assess the patient-reported outcomes and eyelid position improvement in patients with flaccid facial paralysis undergoing lateral eyelid coupling with a tarsal strip canthoplasty and modified tarsoconjunctival flap to correct eyelid malposition. DESIGN, SETTING, AND PARTICIPANTS Review of medical records of adults with flaccid facial paralysis who underwent a single-stage tarsal strip canthoplasty and modified tarsoconjunctival flap at a tertiary academic center. Inclusion criteria included a minimum of 3 months of follow-up. INTERVENTION The lateral upper and lower eyelid are coupled with the hybrid tarsoconjunctival flap. MAIN OUTCOMES AND MEASURES Patient-reported outcome measures and objective photograph analysis. Preoperative and postoperative Facial Clinimetric Evaluation (FaCE) scores and Moe Ectropion Grading Scale scores were compared. The relationship between radiation therapy (RT) and outcomes was analyzed. RESULTS Sixteen patients (8 [50{\%}] female; mean [SD] age at surgery, 71.5 [9.6] years) were identified between January 2014 and August 2017. Twelve (75{\%}) had paralysis from facial nerve sacrifice during cancer ablation. The mean time between paralysis and referral for surgical repair of ectropion was 23 months (range, 0-151 months) and mean follow-up after surgery was 9.8 months (range, 3-39 months). The most common symptom was epiphora, which was significantly reduced after surgery (75{\%} vs 25{\%}; P = .01). Median Moe Ectropion Grading Scale score improved from 3 (interquartile range, 2-3) to 0 (interquartile range, 0-1; P < .001). Quality of life measured using the FaCE scale demonstrated a significant improvement in mean eye comfort (from 18.8 [95{\%} CI, 2.3-35.2] to 47.9 [95{\%} CI, 31.9-63.9]; P = .01) and lacrimal control scores (from 12.5 [95{\%} CI, 0-29.2] to 45.8 [95{\%} CI, 29.3-62.3]; P = .03) in the 6 patients in the RT group, but no difference in the 4 patients in the non-RT group. CONCLUSIONS AND RELEVANCE Ocular symptoms, eyelid appearance, and quality of life were improved after lateral eyelid coupling among patients with flaccid facial paralysis and paralytic ectropion. The tarsoconjunctival flap does limit peripheral vision, but is reversible if dynamic eyelid closure is returned with nerve grafting.",
author = "Raj Dedhia and Hsieh, {Tsung Yen} and Oliver Chin and Shipchandler, {Taha Z.} and Tollefson, {Travis Tate}",
year = "2018",
month = "9",
day = "1",
doi = "10.1001/jamafacial.2018.0070",
language = "English (US)",
volume = "20",
pages = "381--386",
journal = "JAMA Facial Plastic Surgery",
issn = "2168-6076",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Outcomes from lateral eyelid coupling for facial paralysis using the modified tarsoconjunctival flap

AU - Dedhia, Raj

AU - Hsieh, Tsung Yen

AU - Chin, Oliver

AU - Shipchandler, Taha Z.

AU - Tollefson, Travis Tate

PY - 2018/9/1

Y1 - 2018/9/1

N2 - IMPORTANCE In the setting of facial paralysis, inadequate eyelid closure and lower eyelid ectropion can lead to corneal exposure and impaired quality of life. Repair of paralytic ectropion is challenging, and an ideal surgical approach for all cases has not been identified. OBJECTIVE To assess the patient-reported outcomes and eyelid position improvement in patients with flaccid facial paralysis undergoing lateral eyelid coupling with a tarsal strip canthoplasty and modified tarsoconjunctival flap to correct eyelid malposition. DESIGN, SETTING, AND PARTICIPANTS Review of medical records of adults with flaccid facial paralysis who underwent a single-stage tarsal strip canthoplasty and modified tarsoconjunctival flap at a tertiary academic center. Inclusion criteria included a minimum of 3 months of follow-up. INTERVENTION The lateral upper and lower eyelid are coupled with the hybrid tarsoconjunctival flap. MAIN OUTCOMES AND MEASURES Patient-reported outcome measures and objective photograph analysis. Preoperative and postoperative Facial Clinimetric Evaluation (FaCE) scores and Moe Ectropion Grading Scale scores were compared. The relationship between radiation therapy (RT) and outcomes was analyzed. RESULTS Sixteen patients (8 [50%] female; mean [SD] age at surgery, 71.5 [9.6] years) were identified between January 2014 and August 2017. Twelve (75%) had paralysis from facial nerve sacrifice during cancer ablation. The mean time between paralysis and referral for surgical repair of ectropion was 23 months (range, 0-151 months) and mean follow-up after surgery was 9.8 months (range, 3-39 months). The most common symptom was epiphora, which was significantly reduced after surgery (75% vs 25%; P = .01). Median Moe Ectropion Grading Scale score improved from 3 (interquartile range, 2-3) to 0 (interquartile range, 0-1; P < .001). Quality of life measured using the FaCE scale demonstrated a significant improvement in mean eye comfort (from 18.8 [95% CI, 2.3-35.2] to 47.9 [95% CI, 31.9-63.9]; P = .01) and lacrimal control scores (from 12.5 [95% CI, 0-29.2] to 45.8 [95% CI, 29.3-62.3]; P = .03) in the 6 patients in the RT group, but no difference in the 4 patients in the non-RT group. CONCLUSIONS AND RELEVANCE Ocular symptoms, eyelid appearance, and quality of life were improved after lateral eyelid coupling among patients with flaccid facial paralysis and paralytic ectropion. The tarsoconjunctival flap does limit peripheral vision, but is reversible if dynamic eyelid closure is returned with nerve grafting.

AB - IMPORTANCE In the setting of facial paralysis, inadequate eyelid closure and lower eyelid ectropion can lead to corneal exposure and impaired quality of life. Repair of paralytic ectropion is challenging, and an ideal surgical approach for all cases has not been identified. OBJECTIVE To assess the patient-reported outcomes and eyelid position improvement in patients with flaccid facial paralysis undergoing lateral eyelid coupling with a tarsal strip canthoplasty and modified tarsoconjunctival flap to correct eyelid malposition. DESIGN, SETTING, AND PARTICIPANTS Review of medical records of adults with flaccid facial paralysis who underwent a single-stage tarsal strip canthoplasty and modified tarsoconjunctival flap at a tertiary academic center. Inclusion criteria included a minimum of 3 months of follow-up. INTERVENTION The lateral upper and lower eyelid are coupled with the hybrid tarsoconjunctival flap. MAIN OUTCOMES AND MEASURES Patient-reported outcome measures and objective photograph analysis. Preoperative and postoperative Facial Clinimetric Evaluation (FaCE) scores and Moe Ectropion Grading Scale scores were compared. The relationship between radiation therapy (RT) and outcomes was analyzed. RESULTS Sixteen patients (8 [50%] female; mean [SD] age at surgery, 71.5 [9.6] years) were identified between January 2014 and August 2017. Twelve (75%) had paralysis from facial nerve sacrifice during cancer ablation. The mean time between paralysis and referral for surgical repair of ectropion was 23 months (range, 0-151 months) and mean follow-up after surgery was 9.8 months (range, 3-39 months). The most common symptom was epiphora, which was significantly reduced after surgery (75% vs 25%; P = .01). Median Moe Ectropion Grading Scale score improved from 3 (interquartile range, 2-3) to 0 (interquartile range, 0-1; P < .001). Quality of life measured using the FaCE scale demonstrated a significant improvement in mean eye comfort (from 18.8 [95% CI, 2.3-35.2] to 47.9 [95% CI, 31.9-63.9]; P = .01) and lacrimal control scores (from 12.5 [95% CI, 0-29.2] to 45.8 [95% CI, 29.3-62.3]; P = .03) in the 6 patients in the RT group, but no difference in the 4 patients in the non-RT group. CONCLUSIONS AND RELEVANCE Ocular symptoms, eyelid appearance, and quality of life were improved after lateral eyelid coupling among patients with flaccid facial paralysis and paralytic ectropion. The tarsoconjunctival flap does limit peripheral vision, but is reversible if dynamic eyelid closure is returned with nerve grafting.

UR - http://www.scopus.com/inward/record.url?scp=85053817005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053817005&partnerID=8YFLogxK

U2 - 10.1001/jamafacial.2018.0070

DO - 10.1001/jamafacial.2018.0070

M3 - Article

C2 - 29621372

AN - SCOPUS:85053817005

VL - 20

SP - 381

EP - 386

JO - JAMA Facial Plastic Surgery

JF - JAMA Facial Plastic Surgery

SN - 2168-6076

IS - 5

ER -